Magnesium Sulfate vs Placebo for Placental Abruption
- Conditions
- Abruptio Placentae
- Interventions
- Other: Normal Saline
- Registration Number
- NCT00186069
- Lead Sponsor
- Stanford University
- Brief Summary
To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.
- Detailed Description
We hope to learn if there is a difference in the efficacy of intravenous magnesium sulfate versus intravenous saline infusion in the resolution of vaginal bleeding and contractions in patients with a suspected placental abruption.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 30
- vaginal bleeding and contractions consistent with suspected placental abruption between 24 and 34 weeks gestation.
- preterm labor, severe bleeding necessitating immediate delivery, maternal coagulopathy, fetal distress
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Magnesium Sulfate Magnesium Sulfate Magnesium Sulfate 4 gram bolus, followed by 2 grams per hour Normal Saline Normal Saline Normal Saline 4 gram bolus, followed by 2 grams per hour
- Primary Outcome Measures
Name Time Method Undelivered With Resolution of Vaginal Bleeding and Contractions in First 48 Hours 48 hours after the randomization The primary outcome was the proportion of women undelivered at 48 hours with resolution of vaginal bleeding and uterine contractions.
- Secondary Outcome Measures
Name Time Method Neonatal Apgar Score at 5 Minutes At 5 minutes after birth The median Apgar score at 5 minutes. Apgar score scale is from 0 to 10 with score 0 expressing the worst neonatal status and score 10 the best status.
Gestational Age at Delivery (Weeks) Time of delivery Median gestational age at delivery (in full weeks)
Trial Locations
- Locations (2)
Stanford University School of Medicine
🇺🇸Stanford, California, United States
Santa Clara Valley Medical Center
🇺🇸San Jose, California, United States